HCW Biologics Inc. (HCWB)
NASDAQ·Healthcare·Biotechnology
$0.40
-9.81%
Mkt Cap $1.28M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | $7.01M | $5.40M | -22.97% | -$0.84 | -$2.63 | -213.10% | — | — |
| Q4 2025 Nov 14, 2025 | $7.00M | $15.61K | -99.78% | $1.58 | -$2.02 | -227.85% | — | — |
| Q3 2025 Aug 18, 2025 | $7.00K | $6.55K | -6.43% | $1.80 | -$6.79 | -477.22% | — | — |
| Q2 2025 May 15, 2025 | — | $5.07K | — | — | -$0.05 | — | — | — |
| Q1 2025 Mar 28, 2025 | $7.00M | $394.80K | -94.36% | $3.60 | -$3.20 | -188.89% | — | — |
| Q4 2024 Nov 14, 2024 | — | $426.42K | — | -$5.20 | -$4.00 | +23.08% | — | — |
| Q3 2024 Aug 14, 2024 | — | $618.85K | — | -$7.20 | -$16.00 | -122.22% | — | — |
| Q2 2024 May 15, 2024 | — | $1.13M | — | — | -$8.00 | — | — | — |
| Q1 2024 Mar 26, 2024 | — | $1.32M | — | — | -$0.15 | — | — | — |
| Q4 2023 Nov 14, 2023 | $600.00K | $853.10K | +42.18% | -$0.13 | -$5.60 | -4207.69% | — | — |
| Q3 2023 Aug 11, 2023 | — | $622.81K | — | -$0.15 | -$4.80 | -3100.00% | — | — |
| Q2 2023 May 9, 2023 | $2.30M | $41.88K | -98.18% | -$0.14 | -$5.60 | -3900.00% | — | — |
| Q1 2023 Mar 28, 2023 | — | $1.34M | — | -$0.16 | -$6.00 | -3650.00% | — | — |
| Q4 2022 Nov 7, 2022 | — | $1.81M | — | -$0.12 | -$5.60 | -4566.67% | — | — |
| Q3 2022 Aug 12, 2022 | — | $454.00K | — | -$0.12 | -$4.00 | -3233.33% | — | — |
| Q2 2022 May 13, 2022 | $2.64T | $3.12M | -100.00% | -$0.11 | -$2.40 | -2081.82% | — | — |
| Q1 2022 Mar 29, 2022 | — | — | — | -$0.12 | -$0.17 | -41.67% | — | — |
| Q4 2021 Nov 12, 2021 | — | — | — | — | -$5.60 | — | — | — |
| Q3 2021 Aug 13, 2021 | — | — | — | — | -$0.08 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$0.08 | — | — | — |